Help Sitemap Home Skip Navigation Contact Us Disability Statement


Tour syringes to be probed

Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

Published Date: 14 October 2009
FRENCH prosecutors have launched a preliminary investigation to examine syringes found during this year's Tour de France.
The case was opened after the discovery of several suspicious syringes in a container given by organisers to all the teams in order to collect medical waste, the Paris prosecutors office said yesterday, on the eve of the 2010 Tour course unveiling in
Paris.

However, the office said it was not targeting a specific team, refuting a report by L'Equipe yesterday that said Astana was being investigated.

Tour winner Alberto Contador and third-placed Lance Armstrong rode with Astana in this year's race. The Spaniard is still under contract with the Kazakh-funded team, while the Texan left to launch his own squad, RadioShack. According to L'Equipe, the syringes will be analysed by a lab called Toxlab.

While there were no positive tests at this year's Tour, authorities did seize drugs that the French anti-doping agency's scientific adviser said raised questions. The drugs – which include treatments for diabetes, high blood pressure and convulsions suffered by manic-depressives – are not banned but are "incongruous" in top-level athletes, said Professor Michel Rieu last week. Rieu declined to say which teams the substances had been taken from.







Page 1 of 1

  • Last Updated: 13 October 2009 9:50 PM
  • Source: The Scotsman
  • Location: Edinburgh
  • Related Topics: Tour de France
 
 

Comment on this Story

 

In order to post comments you must Register or Sign In

 
 
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.